Pages that link to "Item:Q1906159"
From MaRDI portal
The following pages link to An analytic method for randomized trials with informative censoring. I (Q1906159):
Displaying 20 items.
- Chop-Lump Tests for Vaccine Trials (Q109179) (← links)
- Semiparametric estimation of treatment effect with time-lagged response in the presence of informative censoring (Q415597) (← links)
- Semicompeting risks in aging research: methods, issues and needs (Q509854) (← links)
- Identifiability conditions for covariate effects model on survival times under informative censoring (Q973166) (← links)
- An analytic method for randomized trials with informative censoring. II (Q1126016) (← links)
- Methods for Conducting Sensitivity Analysis of Trials with Potentially Nonignorable Competing Causes of Censoring (Q3078688) (← links)
- Inference in Randomized Studies with Informative Censoring and Discrete Time-to-Event Endpoints (Q3078746) (← links)
- An Audit Strategy for Progression-Free Survival (Q3100818) (← links)
- A Bayesian model for time-to-event data with informative censoring (Q3303820) (← links)
- Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates (Q3434119) (← links)
- Evaluating Candidate Principal Surrogate Endpoints (Q3549407) (← links)
- On Assessing Surrogacy in a Single Trial Setting Using a Semicompeting Risks Paradigm (Q3637000) (← links)
- Estimation of the failure time distribution in the presence of informative censoring (Q4455357) (← links)
- Sensitivity Analyses Comparing Outcomes Only Existing in a Subset Selected Post‐Randomization, Conditional on Covariates, with Application to HIV Vaccine Trials (Q5492070) (← links)
- General Independent Censoring in Event-Driven Trials with Staggered Entry (Q6055746) (← links)
- Discussion on “Causal mediation of semicompeting risks” by Yen‐Tsung Huang (Q6079243) (← links)
- The survival-incorporated median vs the median in the survivors or in the always-survivors: what are we measuring? And why? (Q6560550) (← links)
- Sensitivity analyses for average treatment effects when outcome is censored by death in instrumental variable models (Q6627095) (← links)
- Causal inference for oncology: past developments and current challenges (Q6636227) (← links)
- The balanced survivor average causal effect (Q6637432) (← links)
